1, 2, 4‐Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase. (3rd November 2020)
- Record Type:
- Journal Article
- Title:
- 1, 2, 4‐Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase. (3rd November 2020)
- Main Title:
- 1, 2, 4‐Oxadiazole Topsentin Analogs with Antiproliferative Activity against Pancreatic Cancer Cells, Targeting GSK3β Kinase
- Authors:
- Carbone, Daniela
Parrino, Barbara
Cascioferro, Stella
Pecoraro, Camilla
Giovannetti, Elisa
Di Sarno, Veronica
Musella, Simona
Auriemma, Giulia
Cirrincione, Girolamo
Diana, Patrizia - Abstract:
- Abstract: A new series of topsentin analogs, in which the central imidazole ring of the natural lead was replaced by a 1, 2, 4‐oxadiazole moiety, was efficiently synthesized. All derivatives were pre‐screened for antiproliferative activity against the National Cancer Institute (NCI‐60) cell lines panel. The five most potent compounds were further investigated in various pancreatic ductal adenocarcinoma (PDAC) cell lines, including SUIT‐2, Capan‐1, and Panc‐1 cells, eliciting EC50 values in the micromolar and sub‐micromolar range, associated with significant reduction of cell migration. These remarkable results might be explained by the effects of these new topsentin analogues on epithelial‐to‐mesenchymal transition markers, including SNAIL‐1/2 and metalloproteinase‐9. Moreover, flow cytometric analysis after Annexin V‐FITC and propidium iodide staining demonstrated that these derivatives enhanced apoptosis of PDAC cells. Keeping with these data, the PathScan intracellular signaling and ELISA array revealed cleavage of caspase‐3 and PARP and a significant inhibition of GSK3β phosphorylation, suggesting this kinase as a potential downstream target of our novel compounds. This was further supported by a specific assay for the evaluation of GSK3β activity, showing IC50 values for the most active compounds against this enzyme in the micromolar range. Abstract : Tip‐topsentins ! 1, 2, 4‐Oxadiazole topsentin analogs were efficiently synthesized. Five derivatives showed highAbstract: A new series of topsentin analogs, in which the central imidazole ring of the natural lead was replaced by a 1, 2, 4‐oxadiazole moiety, was efficiently synthesized. All derivatives were pre‐screened for antiproliferative activity against the National Cancer Institute (NCI‐60) cell lines panel. The five most potent compounds were further investigated in various pancreatic ductal adenocarcinoma (PDAC) cell lines, including SUIT‐2, Capan‐1, and Panc‐1 cells, eliciting EC50 values in the micromolar and sub‐micromolar range, associated with significant reduction of cell migration. These remarkable results might be explained by the effects of these new topsentin analogues on epithelial‐to‐mesenchymal transition markers, including SNAIL‐1/2 and metalloproteinase‐9. Moreover, flow cytometric analysis after Annexin V‐FITC and propidium iodide staining demonstrated that these derivatives enhanced apoptosis of PDAC cells. Keeping with these data, the PathScan intracellular signaling and ELISA array revealed cleavage of caspase‐3 and PARP and a significant inhibition of GSK3β phosphorylation, suggesting this kinase as a potential downstream target of our novel compounds. This was further supported by a specific assay for the evaluation of GSK3β activity, showing IC50 values for the most active compounds against this enzyme in the micromolar range. Abstract : Tip‐topsentins ! 1, 2, 4‐Oxadiazole topsentin analogs were efficiently synthesized. Five derivatives showed high antiproliferative activity against pancreatic cancer cells, with pro‐apoptotic effects. The compounds remarkably reduced the migration of Capan‐1 cells, with a decrease in the activity of MMP‐9 protein levels. The most active oxadiazoles confined viable cells in G2 /M phase and markedly inhibited the kinase activity of GSK3β in vitro . … (more)
- Is Part Of:
- ChemMedChem. Volume 16:Number 3(2021)
- Journal:
- ChemMedChem
- Issue:
- Volume 16:Number 3(2021)
- Issue Display:
- Volume 16, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 16
- Issue:
- 3
- Issue Sort Value:
- 2021-0016-0003-0000
- Page Start:
- 537
- Page End:
- 554
- Publication Date:
- 2020-11-03
- Subjects:
- 1, 2, 4-oxadiazole topsentin analogs -- inhibition of migration -- GSK3β kinase -- PDAC antiproliferative activity -- proapoptotic activity
Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.202000752 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 15778.xml